Our findings revealed that PHF6 positively correlated with TMB in stomach adenocarcinoma (STAD), prostate adenocarcinoma (PRAD), stomach and esophageal carcinoma (STES), BLCA, and LUAD. This evidence concerns the gene PHF6 and gastric adenocarcinoma.